Porsch Lauren, Zhang Hongbin, Paschen-Wolff Margaret, Grosskopf Nicholas, Grov Christian
Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
J Womens Health (Larchmt). 2020 Nov;29(11):1385-1391. doi: 10.1089/jwh.2019.8289. Epub 2020 Jun 30.
To estimate sexual orientation associated disparities in sexually transmitted infection (STI)-related outcomes across multiple dimensions of sexual orientation. Using pooled 2011-2017 National Survey of Family Growth data ( = 16,854), we performed bivariate and multivariable logistic and multinomial regression analyses to estimate associations between sexual identity, behavior in the past 12 months, and attraction, and past-year STI treatment, receipt of the human papillomavirus (HPV) vaccine, and age at first HPV vaccination in cisgender women. Bisexual-identified women (adjusted odds ratio [AOR] = 1.53, 95% confidence interval [CI] = 1.10-2.14) and who were sexually active with both men and women in the past 12 months (AOR = 1.64, 95% CI = 1.03-2.55) had significantly higher odds of past-year STI treatment, compared with their nonsexual minority counterparts. Lesbian-identified women (AOR = 0.44, 95% CI = 0.27-0.75) and women with female partners only (AOR = 0.32, 95% CI = 0.12-0.87) had significantly decreased odds of having initiated the HPV vaccine compared with their heterosexual counterparts. Women with both male and female partners who initiated the HPV vaccine had significantly higher odds of having received the vaccine during the latest age range, 18-25 years old (AOR = 2.32, 95% CI = 1.21-4.45) compared with women with male partners only. Sexual minority women continue to be at risk for poor sexual health outcomes, and these outcomes differ by specific components of sexual orientation.
为了评估性取向在性传播感染（STI）相关结果的多个维度上的差异。利用2011 - 2017年家庭成长全国综合调查数据（n = 16,854），我们进行了双变量和多变量逻辑回归及多项回归分析，以估计性身份、过去12个月的性行为和性吸引力与过去一年的STI治疗、人乳头瘤病毒（HPV）疫苗接种以及顺性别女性首次HPV疫苗接种年龄之间的关联。与非性少数群体女性相比，自我认同为双性恋的女性（调整优势比[AOR]=1.53，95%置信区间[CI]=1.10 - 2.14）以及在过去12个月中与男性和女性都有性行为的女性（AOR = 1.64，95% CI = 1.03 - 2.55）过去一年接受STI治疗的几率显著更高。与异性恋女性相比，自我认同为女同性恋的女性（AOR = 0.44，% CI = 0.27 - 0.75）以及仅与女性有伴侣的女性（AOR = 0.32，95% CI = 0.12 - 0.87）开始接种HPV疫苗的几率显著降低。与仅与男性有伴侣的女性相比，与男性和女性都有伴侣且开始接种HPV疫苗的女性在最晚年龄范围18 - 25岁期间接种疫苗的几率显著更高（AOR = 2.32，95% CI = 1.21 - 4.45）。性少数群体女性仍然面临性健康不良结果的风险，并且这些结果因性取向的特定组成部分而异。
